XPECT COLD RELIEF- acetaminophen guaifenesein phenylephrine hcl tablet 
Cintas Corporation

----------

Xpect Cold Relief

Active ingredients (in each caplet)

Acetaminophen 325 mg
Guaifenesin 200 mg
Phenylephrine HCl 5 mg

Purpose

Pain reliever/fever reducer

Expectorant

Nasal decongestant

Uses

Warnings

Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take

Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include: blisters, rash, skin reddening. If a skin reaction occurs, stop use and seek medical help right away. 

Do not use

Ask a doctor before use if you have

Ask a doctor or pharmacist before use if you are

taking the blood thinning drug warfarin. 

When using this product do not exceed recommended dosage.

Stop use and ask a doctor if

If pregnant or breast-feeding, ask a health professional before use. 

Keep out of reach of children. In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms. 

Directions

Other information

Inactive ingredients

corn starch, crospovidone, flavor, magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glyvol, polyvinyl alcohol, povidone, silicone dioxide, sodium starch glycolate, stearic acid, sucralose, talc, titanium dioxide

Questions? 

1-877-973-2811 Monday-Friday 8:00 AM-5:00 PM

Principal Display Panel - Wrapper

COLD RELIEF

Acetaminophen • Pain Reliever/Fever Reducer

Guaifenesin • Expectorant

Phenylephrine HCl • Nasal Decongestant

2 CAPLETS PER PACKET

DO NOT USE IF PACKET IS DAMAGED OR OPEN

KEEP OUTER PACKAGE FOR COMPLETE PRODUCT INFORMATION

wrapper-01

Principal Display Panel - 80 count Box

COLD RELIEF

Active Ingredients:

Acetaminophen

Guaifenesin

Phenyleprine HCl

Pain Reliever/Fever Reducer

Expectorant

Nasal Decongestant

WORKPLACE READY®

Xpect® First aid

80 Caplets • 40 Packets per Box

box-80

Principal Display Panel - 200 count box

COLD RELIEF

Active Ingredients:

Acetaminophen

Guaifenesin

Phenyleprine HCl

Pain Reliever/Fever Reducer

Expectorant

Nasal Decongestant

WORKPLACE READY®

Xpect® First aid

200 Caplets • 100 Packets per Box

box-200

XPECT COLD RELIEF 
acetaminophen guaifenesein phenylephrine hcl tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42961-112
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg
ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN325 mg
PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE5 mg
Inactive Ingredients
Ingredient NameStrength
STARCH, CORN (UNII: O8232NY3SJ)  
CROSPOVIDONE (UNII: 2S7830E561)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)  
POLYVINYL ALCOHOL, UNSPECIFIED (UNII: 532B59J990)  
POVIDONE (UNII: FZ989GH94E)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
SODIUM STARCH GLYCOLATE TYPE A (UNII: H8AV0SQX4D)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SUCRALOSE (UNII: 96K6UQ3ZD4)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Product Characteristics
ColorpinkScoreno score
ShapeROUNDSize12mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42961-112-1180 in 1 BOX03/29/2021
1NDC:42961-112-102 in 1 PACKET; Type 1: Convenience Kit of Co-Package
2NDC:42961-112-12200 in 1 BOX12/30/2022
2NDC:42961-112-102 in 1 PACKET; Type 1: Convenience Kit of Co-Package
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01303/29/2021
Labeler - Cintas Corporation (056481716)
Establishment
NameAddressID/FEIBusiness Operations
L.N.K. International832867837manufacture(42961-112)

Revised: 12/2023
Document Id: d4fcc094-9cb4-41ea-a967-ca6271ce448e
Set id: 02391d55-32b2-4083-9315-98e9b3650c55
Version: 7
Effective Time: 20231228
 
Cintas Corporation